Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Drug Design, Development and Therapy|June 10, 2025
Population Pharmacokinetics and Pharmacodynamics with Enterohepatic Recirculation of Co-Medication of Rosuvastatin and EzetimibeHyungmi An, Dongseong Shin
Drug Design, Development and Therapy|September 1, 2021
Multivariate Assessment for Bioequivalence Based on the Correlation of Random EffectHyungmi An, Dongseong Shin
Drug Design, Development and Therapy|December 20, 2017
Pharmacokinetic and pharmacodynamic interaction between ezetimibe and rosuvastatin in healthy male subjectsChang Hee Kim, Hyungmi An, Sung Hye Kim, et al.
Advances in Therapy|December 16, 2020
Pharmacokinetic Interaction Between Telmisartan and Rosuvastatin/Ezetimibe After Multiple Oral Administration in Healthy SubjectsChang Hee Kim, Sol Ip Kang, Dongseong Shin
Plos One|June 17, 2020
Changes in Beck Depression Inventory scores in prostate cancer patients undergoing androgen deprivation therapy or prostatectomyDongseong Shin, Sung Ryul Shim, Chang Hee Kim
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Ocular and Plasma Pharmacokinetics of Enavogliflozin Ophthalmic Solution in Preclinical SpeciesMingui Jang, Minsung Kang, Eunseok Lee, et al.
Plos One|October 2, 2018
Comparison of the modified unbounded penalty and the LASSO to select predictive genes of response to chemotherapy in breast cancerOlivier Collignon, Jeongseop Han, Hyungmi An, et al.
Yonsei Medical Journal|January 30, 2024
Retention Rates and Successful Treatment with Antiseizure Medications in Newly-Diagnosed Epilepsy PatientsSungeun Hwang, Hyungmi An, Dong Woo Shin, et al.
Drug Design, Development and Therapy|August 11, 2015
Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteersYoonJung Choi, HyeKyung Han, Dongseong Shin, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|October 26, 2022
Ocular Distribution and Pharmacokinetics of 8-Oxo-2'-Deoxyguanosine: A Novel Therapeutic Candidate of Ocular Surface DiseasesHyewon Chung, Yuseung Ha, Yong Ho Kim, et al.
Pageof 4